Researchers successfully test Alzheimer's vaccine in mice

Alzheimer's disease is an illness of the brain that causes memory loss and other losses in cognitive function, as well as being responsible for over half of all dementia cases. Because there isn't a cure or treatment that can reverse the deterioration of mental function due to Alzheimer's, prevention is often people's best hope of not getting the disease. And now, researchers at the University of New Mexico are working on a preventative treatment in an unlikely form: a vaccine.
While usually vaccines target illnesses that are caused by invasive microorganisms like bacteria and viruses, this one actually targets a protein that is often found in the brains of Alzheimer's patients, reported KRQE, an affiliate of CBS. The protein, called "pathological tau," was successfully cleared by the antibodies in the vaccine when tested on mice with Alzheimer's.
To test the effectiveness of pathological tau's removal, the researchers put the mice through a series of "maze-like tests," in which the mice that received the vaccine did reliably better than those that didn't. But of course, there's still a long road between testing a vaccine on mice and getting it ready for humans.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The researchers, Kiran Bhaskar and Nicole Maphis, still need to secure funding in order to create a vaccine that could be tested in humans. And once that's complete, the FDA approval process could take an additional 5 years. But they're still pleased with the results of their initial study: "I really wanted to take this as a challenge," said Bhaskar, who has been working towards an Alzheimer's cure since 2013.
Read more at KRQE.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Shivani is the editorial assistant at TheWeek.com and has previously written for StreetEasy and Mic.com. A graduate of the physics and journalism departments at NYU, Shivani currently lives in Brooklyn and spends free time cooking, watching TV, and taking too many selfies.
-
July 26 editorial cartoons
Cartoons Saturday's political cartoons include Joe Biden's memoir, PBS funding, and an Obama-Trump comparison
-
5 low ratings cartoons about the Late Show cancellation
Cartoons Artists take on early warning signs, the Gen Z stare, and more
-
Connie Francis: Superstar of the early 1960s pop scene
In the Spotlight The 'Pretty Little Baby' and 'Stupid Cupid' singer has died aged 87
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths